NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Care Facilities · USD

Basel Medical Group Ltd (BMGL) Stock Analysis

Basel Medical Group Ltd (BMGL) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

BMGL

$4.43

+$0.25 (+5.98%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BMGL with… →

BMGL Key Statistics

As of Oct 21, 2026
Trading
Open
$4.20
Previous Close
$4.18
Day's Range
4.07–4.45
52-Week Range
2.56–21.72
Volume
1.20M
Valuation
Market Cap
$6.19M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.42
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.96
Financials (FY)
Revenue (FY)
$11.32M+12.63%
Net Income (FY)
−$10.64M−613.11%
Profit marginThe share of revenue left as profit after all costs and taxes.
−68.20%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.58M
1-Year Return
−77.21%
Dividend and dates
Avg Volume
577.02K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BMGL closed at $4.43, −77.21% over 1 year.

Basel Medical Group Ltd (BMGL) has a market capitalization of $6.19M.

In fiscal 2025, BMGL reported revenue of $11.32M.

BMGL Stock Return by Calendar Year

Basel Medical Group Ltd (BMGL) return since Feb 2025: what $10,000 became

1 year
$10,000 $2,279
−77.21%
Since Feb 2025
$10,000 $831
−91.69%

If you had invested $10,000 in Basel Medical Group Ltd (BMGL) at the close on February 25, 2025, the earliest close on record here, it would have been worth $831 at the close on October 21, 2026: −91.69% in total, −77.83% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−24.66%
2025 (partial year)−88.96%

As of October 21, 2026.

BMGL Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$11.32M−$10.64M−94.0%
2024$10.05M$2.07M20.6%
2023$9.70M$1.78M18.4%
2022$10.66M$1.98M18.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$11.32M$8.77M−$2.18M−$10.64M−94.0%
2024$10.05M$7.80M$2.20M$2.07M20.6%
2023$9.70M$7.36M$2.07M$1.78M18.4%
2022$10.66M$8.48M$2.47M$1.98M18.6%

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

BMGL Valuation vs Medical Care Facilities Median

Median of 54 stocks
MetricBMGLMedical Care Facilities medianvs median
P/S ratio0.420.8752% below
Profit margin−68.20%3.19%71.4 pts below

Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Basel Medical Group Ltd (BMGL) carries a market capitalisation of $6.19M. The company sits in the Healthcare sector, in the Medical Care Facilities industry. Headcount on file is 82.

The most recent close on file for BMGL is $4.43, dated October 21, 2026. That is +$0.25 (+5.98%) against the previous close. The 52-week range on file runs from $2.56 to $21.72. The latest close sits 73.05% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $11.32M. Against the prior fiscal year total of $10.05M, that is a change of +12.63%. The same year closed with a net loss of $10.64M. Profit margin runs at −68.2%. That is 71.4 percentage points below the Medical Care Facilities median of 3.19%. Earnings per share on a trailing basis come to −4.96.

Across the 4 fiscal years on file, revenue moves from $10.66M in 2022 to $11.32M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 0.42. On price-to-sales that is 51.69% below the Medical Care Facilities median of 0.87. The medians here are taken across 54 Medical Care Facilities companies that report the metric.

Daily returns over the trailing 1 year annualize to a volatility of 132.1%. Over the trailing twelve months the total return is −77.21%. The stored price history starts on February 25, 2025, and the total return since then is −91.69%.

Growth & Income

The record shows no dividend for BMGL.

2026 is still running; the total return is −24.66% year to date.

Peer Comparison

Basel Medical Group Ltd (BMGL) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Basel Medical Group Ltd BMGL $6.19M —
HCA Healthcare, Inc. HCA $99.46B 15.4
Tenet Healthcare Corporation THC $21.67B 10.6
Encompass Health Corporation EHC $11.88B 20.2

The Medical Care Facilities industry average P/E ratio is 20.7x. Basel Medical Group Ltd has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$99.46B

 THC

Tenet Healthcare Corporation

$21.67B

 EHC

Encompass Health Corporation

$11.88B

 FMS

Fresenius Medical Care AG

$11.47B

 DVA

DaVita Inc.

$11.28B

 UHS

Universal Health Services, Inc.

$10.78B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Basel Medical Group Ltd

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.

Visit website →